Categories: Wire Stories

Lianhua Qingwen Capsule Obtained Approval in the Philippines, and the Chinese Embassy in the Philippines Issued Statement for Congratulation

SHIJIAZHUANG CITY, China–(BUSINESS WIRE)–Lianhua Qingwen Capsule, a Chinese traditional medicine made by Yiling Pharmaceutical, has played an important role in China�s COVID-19 prevention and control. The herb medicine has the effects of clearing away the plague, detoxifying, releasing lung heat. Lianhua Qingwen has been approved by the Food and Drug Administration of the Philippines and become officially registered in the Philippines. It entered the Philippine market on November 23.

In August 2020, spokesperson from the Embassy of the People’s Republic of China in the Philippines has specially issued The Statement on Lianhua Qingwen Capsule Obtaining Philippine Drug Registration Certificate, to congratulate the approval.

The statement pointed out that the embassy was very pleased to learn the Food and Drug Administration of the Philippines had officially approved Lianhua Qingwen Capsule produced by Yiling Pharmaceutical, making it a traditional Chinese medicine product officially registered in the Philippines.

The statement shows that Lianhua Qingwen Capsule has obtained listing license in nearly 20 countries, including Brazil, Indonesia, Canada, Mozambique, Romania, Thailand, Ecuador, Singapore and Laos. It is expected that after entering the Philippine market, Lianhua Qingwen can help effectively curb the spread of the coronavirus and help Philippine patients with mild symptoms quickly recover.

The Chinese Embassy hopes that Philippine consumers purchase and use qualified traditional Chinese medicine products produced by regular manufacturers, and expect Chinese medicine products to play a greater role in fighting COVID-19 in the Philippines.

It is reported that the registration No. of Lianhua Qingwen in the Philippines is THPR-50, with product category as a traditionally-used herbal product. At present, consumers in the Philippines can purchase Lianhua Qingwen at the Southstar Drug, and is going to be on sale at Watsons and Mercury Drug also.

Contacts

First Name: Li

Last Name: Kristy

E-mail:kristyli@chuhaimedia.com.cn
Phone No.: +86 85962566

Alex

Recent Posts

Zhengzhou: Interactive Exhibitions on the International Museum Day

ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…

4 hours ago

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

14 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago